state union busi cruisin top pick
comp stun guidanc msd comp expect
view conserv rais comp along
favor expect food inflat drive ep higher
respect rais pt rais
ep
link full note
feb new suspect case fell tuesday day
new confirm case rose suspect confirm
posit data point though earli say seen peak hubei
china case china still global case report refin airlin hotel
link full note
pleas see addendum report import disclosur
post strong close expect gener posit
report solid result rev/bil beat driven continu
enterpris platform custom growth y/i rev/bil guid
y/i came pre-print estimate management expect gener
posit vs our/con pre-print estimate loss highlight
scalabl model reiter outperform pt
link full note
disney report ebit result consensu estim disney paid
disney sub continu grow remain outperform rate
rais price target ep
link full note
 guidanc soft headwind net pension guid
capital-expenditure rise visibl low yet fcf/ep upper
valuation/short interest support investor apt return play
link full note
push cloud note avaya engag preview
cloud bust seem avaya primari messag annual user group
forum messag met gener enthusiasm among user channel
partner servic partner spoke excit around avaya cloud
offic mid-market space enterpris palpabl came away
increment construct increasingly-vis stori
link full note
stock weaker ep guid expect meanwhil
caution point includ pressur work busi tough comparison
weather guidanc call flattish margin appreci strong privat brand
momentum ad countri marketing/ product store growth opportun well
msd comp trend
link full note
posit follow call insignific portion
miss rel consensu driven one-tim expens think march
guidanc updat wcg could posit catalyst share see potenti
low sd accret yr upper sd accret yr vs expect least
break-even mid-to-upp sd accret yr
link full note
beat adj ep book adj ep guidanc rang
bracket consensu est encourag management execut sinc arriv
starboard confid l-t revenue growth target think
like better expect look detail around l-t strategi
upcom invest commun meet march
link full note
coheru disclos partner lucenti biosimilar receiv fda
request addit data due appear minor alter
manufactur process specif manufactur equip move within
site appear request data requir month bla
resubmit modest delay alter valuation/thesi
link full note
compani outlook surpris given near-term view us heavi
truck china industri see room optim b/bill improv new
custom opportun asia heavi truck diversifi growth late qti may add
increment rev compani prolifer content
aerospac industri alreadi pay dividend
link full note
lower ep estim china suppli chain disrupt
pois neg impact least model partial make-up
busi keep estim unchang remain
sidelin acknowledg recent weak
link full note
report in-lin result intern revenu growth provid
guidanc dovetail compani initi outlook includ intern
revenu growth adj ep growth view guidanc achiev
forecast sustain adj ep growth
link full note
total revenue vs beat non-gaap ep vs would
ex inventori write-down guidanc product sale
y/i ep y/i impli flat
tepid growth think under-valued cash flow though major re-rat
requir pipelin program capabl drive renew growth
link full note
lot like
reinforc invest thesi remain posit leverag number
promin secular growth driver across product custom market
strong product execut translat strong competit market posit
increas continu see potenti upsid oper forecast
link full note
fda session present preliminari rec talc test methodolog
today fda session talc test methodolog asbesto includ preliminari
recommend workgroup iwgacp public comment multipl
viewpoint debat appropri methodolog continu view
today session signfic needl mover one way reiter
link full note
report strong dec result guid larg in-lin lot
nois right around load run-rat foundri spend lighter
memori rev believ short-term perturb
sale recov later year importantli similar memori
rebound quarterli sequenti start get better
link full note
lone deliv rel in-lin result product ebitdax though
capital-expenditure propens miss spend relat cyclone-hawkey pad come
believ continu downdraft commod price bia lone
outlook toward lower end previou guid
link full note
first blush financi solid tinder sub add lighter side
report solid financi revenue mostli line ebitda beat
tinder sub add q/q estim get color
call guid slightli lower rev/ebitda rev/ebitda guid
maintain tinder guid add vs estimate share
ah review model post call et
link full note
report ep penni our/street estim segment
post better model organ growth adj op margin revenue/ebitda
guid rais high end previous provid rang though street alreadi
need move materi impli ep level slightli
street infrastructur solid tech still uphil battl
link full note
revenu ahead consensu
consist ingrezza sale pre-announce orilissa royalti
expens guidanc reflect upcom pivot trial
anticip launch opicapon full ph ii data adult expect
endo march dcf-base price target
link full note
expect report mix bill in-lin
deal metric retent rate custom weaker q/q posit
impli bill guid nice expect show management convict
pipelin abil execut head pullback look interest ev/
sale value-hunt maintain outperform
link full note
nxp print reflect improv macro compani underli earn
power marvel fold encourag return y/i growth
gm track hit elus estim best broad-bas
play auto semi mcu potenti index inclus help close
valuat gap peer outperform pt
link full note
follow latest signific disappoint reduc oper
forecast lack meaning visibl time magnitud improv
said issu company-specif beand assert larg
redress outlook remain unchang market opportun
on-going prolifer open cloud-bas ucc solut
link full note
beat earn acquir acur nexera gnyha
report better expect result rais guidanc
lower perform servic expect despit beat concern around
acquisit acur nexera gnyha one largest custom like
push share lower believ reaction overblown although remain
concern continu perf svc weak polit uncertainti
link full note
beat expect bar quit low surfac seem
like decent updat howev quantiferon key growth driver much weaker
expect appear weak could linger await addit
detail tomorrow confer call share appear fairli valu
link full note
may earli tell approach near-term peak enterpris
capac shipment think caus conservat margin howev
absolut clear stx continu admir job
control input cost progress toward higher enterpris capac point later
put play remain
link full note
snap review mix result larg opportun horizon
snap post mix result revenue high end guid
estimate ebitda dau better guid also mix dau
revenu better ebitda guid light snap invest behind growth
initi estimate larg unchang follow result guid pt remain
maintain outperform snap ah
link full note
recent review disclosur around steel aluminum deriv product
